Adaptive Memory of Human NK-like CD8+ T-Cells to Aging, and Viral and Tumor Antigens by María Luisa Pita-López et al.
December 2016 | Volume 7 | Article 6161
Mini Review
published: 19 December 2016
doi: 10.3389/fimmu.2016.00616
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Fernando A. Arosa, 
University of Beira Interior, Portugal
Reviewed by: 
Koji Yasutomo, 
University of Tokushima, Japan  
Sian M. Henson, 
Queen Mary University of 
London, UK
*Correspondence:
María Luisa Pita-López 
maria.pita@cusur.udg.mx
Specialty section: 
This article was submitted to 
T Cell Biology, 
a section of the journal 
Frontiers in Immunology
Received: 25 October 2016
Accepted: 06 December 2016
Published: 19 December 2016
Citation: 
Pita-López ML, Pera A and Solana R 
(2016) Adaptive Memory of Human 
NK-like CD8+ T-Cells to Aging, and 
Viral and Tumor Antigens. 
Front. Immunol. 7:616. 
doi: 10.3389/fimmu.2016.00616
Adaptive Memory of Human nK-like 
CD8+ T-Cells to Aging, and viral and 
Tumor Antigens
María Luisa Pita-López1*, Alejandra Pera2,3 and Rafael Solana3
1 Research Center in Molecular Biology of Chronic Diseases (CIBIMEC), CUSUR University of Guadalajara, Guzmán, Mexico, 
2 Clinical Division, Brighton and Sussex Medical School, University of Sussex, Brighton, UK, 3 Maimonides Biomedicine 
Institute of Cordoba (IMIBIC), Reina Sofia Hospital, University of Córdoba, Córdoba, Spain
Human natural killer (NK)-like CD8+ T-cells are singular T-cells that express both T and NK 
cell markers such as CD56; their frequencies depend on their differentiation and activa-
tion during their lifetime. There is evidence of the presence of these innate CD8+ T-cells in 
the human umbilical cord, highlighting the necessity of investigating whether the NK-like 
CD8+ T-cells arise in the early stages of life (gestation). Based on the presence of cell 
surface markers, these cells have also been referred to as CD8+KIR+ T-cells, innate CD8+ 
T-cells, CD8+CD28−KIR+ T-cells or NKT-like CD8+CD56+ cells. However, the functional 
and co-signaling significance of these NK cell receptors on NK-like CD8+ T-cells is less 
clear. Also, the diverse array of costimulatory and co-inhibitory receptors are spatially 
and temporally regulated and may have distinct overlapping functions on NK-like CD8+ 
T-cell priming, activation, differentiation, and memory responses associated with differ-
ent cell phenotypes. Currently, there is no consensus regarding the functional properties 
and phenotypic characterization of human NK-like CD8+ T-cells. Environmental factors, 
such as aging, autoimmunity, inflammation, viral antigen re-exposure, or the presence 
of persistent tumor antigens have been shown to allow differentiation (“adaptation”) of 
the NK-like CD8+ T-cells; the elucidation of this differentiation process and a greater 
understanding of the characteristics of these cells could be important for their eventual 
in potential therapeutic applications aimed at improving protective immunity. This review 
will attempt to elucidate an understanding of the characteristics of these cells with the 
goal toward their eventual use in potential therapeutic applications aimed at improving 
protective immunity.
Keywords: nK-like CD8+ T-cells, memory, T-cell differentiation, immunosenescence, aging, CMv, natural killer 
receptors, CD56
inTRODUCTiOn
T lymphocytes derive their name from their site of maturation in the thymus. In particular, T cyto-
toxic (Tc) cells that express CD8 are activated upon interaction with an MHC-class I complex on the 
surface of an altered-self cell (e.g., virus-infected cell or tumor cell) in the presence of appropriate 
cytokines. T-cell co-signaling is largely context dependent and relies on a diverse array of costimula-
tory and co-inhibitory receptors spatiotemporally regulated, which may have distinct or overlapping 
functions in T-cell priming, activation, differentiation, and memory responses (1). The total cytotoxic 
TABLe 1 | Characterization of nK-like CD8+ T-cells.
Study Cell name Specie Biomarkers Result Reference
The expression of NK receptors 
in PBL from healthy and 
melanoma patients
CD28− cytolytic 
effector T cells
Human CD28− preferential alpha/beta 
TcR+ killer cell immunoglobulin-
like receptor (KIR)+
The percentages of NK receptor-positive  
(p58.1, p58.2, p70, p140, ILT2, NKRP1A, 
ZIN176, CD94, and CD94/NKG2A) T cells  
(NKT cells) varied more strongly between 
melanoma patients
Speiser  
et al. (5)
Changes in the T cell pool 
caused by CMV infection 
contribute to immunosenescence
CD8+ natural killer 
(NK) T-like cells
Human CD56+ NKT-like cell percentage increases with the 
combination of both CMV and age
Hassouneh  
et al. (10)
Eomesodermin-expressing 
innate-like CD8+ KIR/NKG2A+ 
T cells in human adults
KIR/NKG2A+ CD8+ 
T cells
Human KIR+ (NKG2A) innate/memory 
phenotype
Increased Eomes expression, prompt  
IFN-gamma production in response to 
innate-like stimulation by IL-12 + IL-18
Jacomet  
et al. (11)
Review: expansions of NK-like 
alpha/beta TcR T cells with 
chronologic aging
NK-like alpha/beta 
TcR T cells
Human NK cell receptors on aged  
alpha/beta TcR cells
NKR expression on T cells is 
physiologically programed rather than a 
random event of the aging process
Vallejo  
et al. (12)
Regulation of the immune 
response through killing antigen-
bearing DCs
CD8+ NKT-like cells Mice TcR beta CD3 NK1.1+ CD49b+ 
NKG2D+
Secretion of high levels of IFN-gamma, but 
not IL-4
Wang  
et al. (13)
T-cell responses and protective 
immunity
Memory-like effector 
NKT cells
Mice CD44+ CD62L− Coadministration of alpha-GalCer analog 
and TLR4 agonist activates memory-like 
effector NKT cells
Coelho-Dos-Reis 
et al. (14)
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CD8+ T-cell pool is exposed to different microenvironmental 
stimuli (both TcR dependent and independent) and the resulting 
phenotype and cytokine secretion will determine an individual 
T-cell or T-cell clone’s effector or regulating functional capacities, 
including tissue residence/homing and organ homeostasis (2).
In addition to CD8+ T lymphocytes, natural killer (NK) cells 
have a crucial role in the recognition and killing of virus-infected/
tumor cells, but unlike CD8+ T-cells, they use a repertoire of 
germ-line encoded inhibitory/activating receptors that recognize 
“missing self ”/“altered-self ” antigens on the target cells leading 
to cytotoxicity and cytokine production (3). These NK cell recep-
tors (NKRs) are also expressed on certain subsets of T-cells. One 
example is NKR-CD56, which has been found to be elevated in 
both peripheral blood cells and in tumor-infiltrating lymphocytes 
in patients with colorectal cancer (4). In many clinical circum-
stances, the expression of different NKRs on T-cells is associated 
with prolonged antigen stimulation, suggesting that these recep-
tors play a crucial role in the homeostasis of antigen-experienced 
T-cells.
Cumulative evidence supports the existence of T-cell subsets, 
with characteristics that bridge innate and adaptive immunity, 
which are relevant in inflammation and viral and tumor surveil-
lance, and which could have a role in the pathogenesis of autoim-
mune diseases. These NKR-expressing cytotoxic T lymphocytes 
(CTL) have been termed NK T (NKT) cells. Thus, NKT cells are 
naturally occurring, although rare, T-cells that express both T and 
NK cell receptors (5). However, there is some confusion with the 
use of the term “NKT-cell.” On one hand, CD1d-restricted cells, 
which have a semi-invariant TcR, are frequently called NKT-cells 
or invariant NKT (iNKT) cells; on the other hand, highly special-
ized effector memory CD8+ T-cells expressing NKRs are also 
referred as NKT-like cells. Therefore, to avoid confusion, we will 
call the later, NK-like CD8+ T-cells.
Natural killer-like CD8+ T-cell differentiation occurs after 
the induction of transduction signals that activate/inhibit the 
expression of certain CD8+ T-cells genes, determining the 
activation state, proliferation, and differentiation (6). Indeed, 
prolonged antigen stimulation may induce changes in the CD8+ 
T-cell receptor repertoire leading to the expression of NKRs; 
and chronic antigen stimulation of T cells also leads to other 
phenotypic changes such as the loss of costimulatory molecules 
(e.g., CD28) (5). Usually, CD8+ T-cell memory subsets display 
specific responses based on the expression of killer cell immu-
noglobulin-like receptors (KIRs) used to distinguish unhealthy 
cellular targets from the healthy host cells (7, 8). However, high 
antigen concentrations can bypass the KIR-mediated inhibition 
of T-cell activation. Dynamic KIR expression may mediate T-cell 
tolerance to self-antigens by down regulating self-reactive T-cells 
(9). Nevertheless, the functional significance of the inhibitory or 
activating NKRs on NK-like CD8+ T-cells is still unclear.
Natural killer-like CD8+ T-cells have been described using 
different names, for example: CD56+CD8+ NKT-like cells (10), 
CD28−KIR+ CD8+ T-cells (5), KIR+CD8+ T-cells—particularly 
those expressing NKG2A—(11), or the general term innate CD8+ 
T-cells—since NKR+ αβT-cells likely represent immune effector 
cells that are capable of combining innate and adaptive functions 
(12). Table 1 summarizes the most relevant information regard-
ing the characterization of NK-like CD8+ T-cells.
In both the human umbilical cord and in healthy adults, an 
“innate/memory-like” CD8+ T-cell subset that expresses KIR 
and NKG2A has been described. These cells were EOMEShi, 
exhibited potent antigen-independent cytotoxic activity, and 
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produced IFN-gamma in response to IL-12 +  IL-18 (11). The 
differentiation of these cells, similar to that of the overall pool 
of CD8+ T-cells, can be influenced by aging. Specifically, age has 
been associated with increased susceptibility to infections and 
inflammatory diseases (15), cancer, and autoimmunity (16). 
The differentiation of human NK-like CD8+ T-cells is initiated 
after viral/tumor antigen priming and may be influenced by 
other factors such as aging, autoimmunity, or inflammation. 
These cytotoxic CD8+ T-cells, when activated, implement a dif-
ferential expression of NKRs, leading to memory and migration 
responses. According to the expression of the CD8 marker on 
their surface, these cells are classified as bright or dim and display 
different functional properties (Figure 1A). In this context, we 
reviewed the literature regarding NK-like CD8+ T-cells and their 
phenotypic characterization associated with viral infection, 
immunosenescence, and diseases.
PHenOTYPiC CHARACTeRiZATiOn OF 
nK-LiKe CD8+ T-CeLLS
Immunological memory is the ability of the immune system to 
respond more rapidly and effectively to previously encountered 
pathogens. This is a classical feature of adaptive immunity, which 
is derived from unique patterns of gene expression. A faster and 
stronger transcription of previously activated genes occurs in 
memory T-cells compared with naïve cells. This ability to remem-
ber past transcriptional responses is termed “adaptive transcrip-
tional memory” (18). After acute infections, CD8+ T-cell memory 
differentiation leads to the generation of functionally distinct 
populations, with either proliferative potential or cytotoxic effec-
tor functions, that recirculate into lymphoid tissues or remain 
tissue-resident (6). This phenomenon depends on the expression 
of several receptors, including the C-C chemokine receptor 7 
(CCR7) and CD45RA, which have been used to discriminate naïve 
(N; CD45RA+CCR7+), central memory (TCM; CD45RA−CCR7+), 
transitional memory (TTM; CD45RA−CCR7−), and terminally 
differentiated T-cells (TEMRA or TTE: CD45RA+CCR7−) (15). A fur-
ther classification divides the CCR7−CD8+ T-cell subpopulation 
into three distinct memory subsets according to the expression of 
CD45RA: CD45RAnull, CD45RAdim, and CD45RAbright (19).
There are several models of memory CD8+ T-cell differentia-
tion (20) and two new subsets have been recently described: the 
“stem cell-like memory T-cells” (TSCM) (21) and the “transitional 
memory (TTM) T-cells” (17). Differentiation of circulating 
memory CD8+ T-cells starts after antigen challenge and subse-
quent naïve T-cell activation. The recently described progressive 
differentiation model proposes that the fate of the T-cells depends 
on the duration of signaling and the presence or absence of 
cytokines. Thus, a single naïve cytotoxic T lymphocyte will dif-
ferentiate gradually to different memory subsets (Figure 1B). In 
consequence, brief antigen stimulation will generate TCM and TTM 
cells, while sustained stimulation together with the presence of 
cytokines will lead to TEM and TTE (TEMRA) cells that re-express 
CD45RA (17, 22–24). Additionally, another type of memory cell 
has been described, the “resident memory T-cells” (TRM), which 
are non-recirculating memory T-cells with long-term persistence 
in epithelial barrier tissues. As shown in Figure 1B, it is prob-
able that NK-like CD8+ T-cells emerge from TTM, TEM, or TTE 
CD8+ T-cell phenotypes; these cells could be circulating or tissue 
resident.
In addition, some authors suggest that the CD45RO+CD45RA− 
T-cells comprise diverse memory subsets, including TCM, TSCM, 
TEM, and TRM subsets, which are heterogeneous in their genera-
tion, distribution, and function (24). Thus, TRM cells may persist 
in the absence of antigens and display several effector functions. 
Moreover, TRM cells could have evolved to provide rapid immune 
protection against pathogens. However, autoreactive, aberrantly 
activated, and malignant TRM cells can contribute to numerous 
human inflammatory diseases (25).
CD8+ T-cells in lymphoid tissues are naïve, while in mucosal 
sites, these cells are IFN-gamma producing TEM cells. The T-cell 
activation marker, CD69, is constitutively expressed by memory 
T-cells in all tissues, distinguishing them from circulating subsets. 
TRM cells expressing CD69 are also present in human mucosal and 
peripheral tissue sites (24). However, the mucosal memory T-cells 
exhibit additional distinct phenotypic and functional properties 
(26). In particular, human intrahepatic lymphocytes are rich in 
CD1d-unrestricted T-cells that co-express NKRs (NK-like CD8+ 
T-cells), and it is possible that the hepatic epithelial cells and the 
cytokine milieu play a role in the shaping of these cells. For exam-
ple, IL-15 is capable of inducing Ag-independent upregulation of 
NKRs in the CD8+CD56− T-cells. This increased percentage of 
intrahepatic NK-like CD8+ T-cells could be in part due to a local 
CD8+ T-cell differentiation (27) and could explain how NK-like 
CD8+ T-cells differentiate in the human liver.
The distribution and tissue residence of naïve, central and 
effector memory, and terminal effector subsets is contingent on 
both their differentiation state and tissue localization. Moreover, 
T-cells homeostasis, driven by cytokine or TcR-mediated signals, 
is different in CD4+ or CD8+ T-cell lineages and varies with their 
differentiation stage and tissue localization (28). In this sense, it 
is important to investigate NK-like CD8+ T-cells with respect to 
memory phenotype, functional properties, and long-term dif-
ferential fates following acute infection or chronic diseases.
nK-LiKe CD8+ T-CeLLS in viRUS 
inFeCTiOn AnD iMMUnOSeneSCenCe
Throughout an individual’s lifetime, the memory T-cell percent-
age undergoes dynamic changes that can be classified into three 
phases: memory generation during infancy and early childhood, 
memory homeostasis, which occurs after age 20–25, and immu-
nosenescence (24). This last term refers to the deterioration of 
the immune system associated with aging, and it is characterized 
by substantial alterations of the T-lymphocyte subsets (29). An 
increased expression of NK cell markers on T-cells has been 
reported to be associated with aging and chronic activation of 
the immune system, as reflected in the accumulation of effector/
senescent T-cells (30). This memory subpopulation is interesting, 
because the senescence of human TTE CD8+ T-cells is stringently 
controlled by distinct and reversible cell signaling events (31). 
Also, there is evidence of a differential regulation of NKR 
FiGURe 1 | Continued  
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(A) Differentiation of human NK-like CD8+ T-cells and expression of TcR. The total pool of cytotoxic CD8+ T-cells is exposed to different TcR-alpha/beta and 
TcR-gamma/delta dependent or independent microenvironmental stimuli. From this pool originate the NK-like CD8+ T cells, which can be induced by the 
transduction of signals that activate or inhibit gene expression that, in turn, determines cytokine secretion, effector/regulating functions, migration/tissue retention, 
activation state, proliferation, and differentiation. Other factors that influence this process are aging, autoimmunity, inflammation, and the presence of viral and tumor 
antigens. (B) Differentiation of human NK-like CD8+ T-cell memory. Differentiation of CD8+ T-cell memory starts after naïve T-cell activation. According to the recently 
proposed model of progressive differentiation, the fate of T-cells depend on the duration of signaling and the presence or absence of cytokines (17). Thus, a single 
naïve cytotoxic T lymphocyte will differentiate gradually to different memory subsets: stem cell memory (TSCM), central memory (TCM), transitional memory (TTM) cells, 
effector memory (TEM), and terminally differentiated effector memory (TTE). In consequence, brief antigen stimulation will generate TCM cells and TTM cells, the later 
being more differentiated than TCM cells but not as fully differentiated as TEM cells, in terms of phenotype. On the other hand, sustained stimulation together with 
presence of cytokines will generate TEM and TTE cells, which most probably include NK-like CD8+ T cells both circulating or tissue resident.
FiGURe 1 | Continued
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expression between T-cells and NK cells suggesting that NKR 
expression on T-cells is physiologically programed rather than a 
random event of the aging process (12). This may suggest that the 
NK-like CD8+ T-cells have a functional plasticity with respect to 
their “adaptation” that allows them to respond to different stimuli.
CMV and HIV infection strongly affect CD8+ T-cell differen-
tiation and maturation, enhancing immunosenescence due to the 
accumulation of highly differentiated TEM and TTE cells (32, 33). 
The CD57 antigen has been traditionally used to characterize ter-
minally differentiated “senescent” cells, as CD57+ T-cells exhibit 
a reduced proliferative capacity and altered functional properties 
(34). Of note, the expansion of CD57+CD8+ T-cells is a hallmark 
of latent CMV infection (35). The CD57+CD8+ T-cell subset is 
functionally heterogeneous, and includes highly cytotoxic TTE 
cells that express intermediate levels of EOMES, as well as non-
cytotoxic EOMEShi TTE cells with high proliferative capacity (36). 
These above-referenced studies highlight the existence of func-
tional heterogeneity among the CD8+ T-cell memory subsets. 
Regarding NK-like CD8+ T cells, high percentages of these cells 
also express the CD57 marker and likewise arise after CMV infec-
tion (10). It has been well established that NK-like CD8+ T-cells 
expand with age (30, 37–39) and some studies suggest that their 
frequency is increased in CMV-seropositive individuals (40–42). 
However, recent work performed in healthy young individuals 
indicates that NK-like CD8+ T-cell frequency is not affected by 
CMV latent infection. Thus, the authors propose that these cells 
accumulate with age in the CMV-seropositive individuals, rather 
than with CMV infection per se (10).
Moreover, NK-like CD8+ T-cells from Epstein–Barr virus 
(EBV)-associated tumor patients are quantitatively and func-
tionally impaired and in a human-thymus-SCID chimera model, 
the EBV-induced human NK-like CD8+ T-cells synergize with 
NK-like CD4+ T-cells suppressing EBV-associated tumors upon 
induction of a Th1-bias (43). Additionally, in women with human 
papillomavirus (HPV)-associated cervical neoplasia, there are 
increased levels of CD28−, TEM, and CD16+CD56+ CD8+ T-cells 
in peripheral blood, probably associated with the chronic infec-
tion with HPV (44). As we mentioned above, NK-like CD8+ 
T-cells possess a diverse TcR repertoire and there is evidence that 
these cells can function as antigen-specific suppressive cells that 
regulate the immune response through killing antigen-bearing 
dendritic cells (13). The class-I MHC-restricted T-cell-associated 
molecule (CRTAM) has been shown to be expressed only on 
activated class-I MHC-restricted T-cells, including NK-like 
CD8+ and conventional CD8+ T-cells. Of note, this molecule is a 
surface marker of activation associated with human viral infec-
tions and autoimmune diseases (45). These studies show that the 
NK-like CD8+ T-cells interact with other cells and that chronic 
stimulation determines their phenotype.
nK-LiKe CD8+ T-CeLLS AnD DiSeASe
There is evidence in the literature of an immune suppressor role 
for the CD8+CD28− T-cells (Ts) and the CD3+CD56+ T-cells. 
Patients with B-cell non-Hodgkin’s lymphoma had significantly 
higher percentages of Ts cells and NKT-like cells than healthy peo-
ple, suggesting that, in this type of lymphoma, these cell subsets 
may possibly have an immunosuppressive role (46). It has been 
suggested that tumor-induced dysfunction of CTL in patients 
with multiple myeloma may contribute to immune escape and 
causes clonal T-cell immunosenescence, but not exhaustion, as a 
predominant feature. These cells exhibited a senescent secretory 
effector phenotype: KLRG-1+/CD57+/CD160+/CD28− (47) and 
may possibly be NK-like CD8+ T-cells with TEM or TTE phenotype. 
Furthermore, the use of ex vivo-expanded NK and NK-like T-cells 
has been reported seems to be safe and it could be an approach for 
further clinical evaluation in cancer patients (47).
Patients with Behcet’s uveitis also showed an increased 
number of CD8+ T-cells and CD8+CD56+ (NKT-like) cells in the 
aqueous humor, indicating a possible role for these subsets in the 
immunopathogenesis of the disease (48). CD56+CD8+ NKT-cells 
express more IFN-gamma and KIR in patients with leishmaniasis 
compared with healthy subjects (49). Similarly, loss of CD28 was 
associated with an increased percentage of T and NK-like T-cells 
producing IFN-gamma or TNF-alpha in patients with chronic 
obstructive pulmonary diseases (44). Furthermore, targeting 
peripheral blood pro-inflammatory CD28− T-cells and NK-like 
CD8+ T-cells by inhibiting CD137 expression may possibly be of 
relevance to the treatment of bronchiolitis obliterans syndrome 
(50). In this regard, the percentage of CD57+CD8+ T-cells is the 
strongest immunologic predictor of future cutaneous squamous 
cell carcinoma and was correlated with increasing CD8+ T-cell 
differentiation (36). As mentioned above, a high percentage of 
CD57+CD8+ T cells are NK-like.
The human activating receptor NKG2D recognizes a diverse 
family of ligands (MICA, MICB, and ULBPs 1–6), leading to 
the activation of effector cells and triggering the lysis of target 
T-cells. Differential expression of NKG2D is regulated in the dif-
ferent T-cell subsets by epigenetic mechanisms (51). The NKG2D 
receptor–ligand system plays an important role in the immune 
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response to infections, tumors, transplanted grafts, and autoan-
tigens. In lung cancer patients, NK-like CD8+ T-cells exhibit low 
expression of NKG2D, which correlates with the pathological 
stage (52). Thus, understanding the regulation of human NK-like 
CD8+ T-cells activation could be a strategy to manipulate T-cell-
mediated responses including tumoral responses and infections.
Patients with Behcet’s uveitis also showed an increased 
number of CD8+ T-cells and CD8+CD56+ (NKT-like) cells in the 
aqueous humor, indicating a possible role for these subsets in the 
immunopathogenesis of the disease (48). A skewed distribution 
and lower frequencies of circulating activated CD161+ NK-like 
CD8+ T-cells was observed in patients with common variable 
immunodeficiency disorders, suggesting a probable regulatory 
function of these cells (53). CD161 is expressed by several 
T-cell subsets, including CD8+, NK-like CD8+, CD4+, and TcR-
gamma/delta cells and all CD161+ lymphocytes display a shared 
innate response to IL-12 +  IL-18 in which CD161 can act as a 
costimulatory receptor (54). Additionally, IL-23 responsiveness 
is restricted to the CD161+ subset in CD45RO+CD8+ memory 
T-cells (55). Moreover, both the frequency and the absolute 
number of CD161+CD8+ T-cells are decreased in the peripheral 
blood of patients suffering from systemic lupus erythematosus 
(56). A skewed distribution and lower frequencies of circulating 
activated CD161+ NK-like CD8+ T-cells was observed in patients 
with common variable immunodeficiency disorders, suggesting 
a probable regulatory function of these cells (53).
Finally, evidence from murine research has shown that har-
nessing the immune adjuvant properties of NK-like CD8+ T-cells 
can be an effective strategy to generate immunological memory 
and anticancer immunity. This effect was associated with the IFN-
gamma-dependent expansion of KLRG1+CD8+ effector T-cells 
(57). Another study in mice assessed the vaccine induction of 
CD8+ T-cell responses and protective immunity after coadmin-
istration of alpha-GalCer analog and TLR4 agonist. The results 
showed a robust CD8+ T-cell response to PyCS protein and WT-1 
antigen and activation of memory-like effector NK-like CD8+ 
T-cells, with a CD44+CD62L− phenotype (14).
FUTURe ReSeARCH COnSiDeRATiOnS
This review supports the concept that NK-like CD8+ T-cells are 
part of a cell subset associated with the acquisition of differential 
marker profiles, although there is little information regarding the 
functional properties of these cells in humans. Thus, there are 
several questions to clarify. First, are NK-like CD8+ T-cells CD3+/
CD8+/CD56+ bright or dim? Second, are they TcR-alpha/beta+, 
TcR-gamma/delta+, or TcR-gamma/delta−? Third, do these cells 
contain variant or semi-invariant chains? Fourth, do they have 
CD8+/alpha-beta or CD8+/alpha-alpha? It would also be inter-
esting to evaluate whether these subpopulations differ in their 
abilities to stimulate other immune cells and if they have diverse 
immunoregulatory functions including activation/suppression 
of diverse cells. Additionally, more information is needed with 
regards to how different environmental factors, such as autoim-
munity, inflammation, viral antigen re-exposure, or persistent 
tumor antigens might allow the differentiation (“adaptation”) 
of the memory NK-like CD8+ T-cells. Finally, it is important to 
be cognizant of the different NK/T-cell-like cell populations and 
exclude the NK-like CD8+ T-cells when analyzing the immune 
responses mediated by conventional CD8+ T-cells and vice versa.
Nutrient/metabolic regulators can influence NK-like CD8+ 
T-cell differentiation, which could be analyzed through nutrig-
enomics contributing to the knowledge regarding the differentia-
tion of this subset. As the balance between activating/inhibitory 
receptors controls NK-like CD8+ T-cells immune responses, it 
should also be considered that the expression of these receptors 
could depend on the cell differentiation state, the age, and/or 
diseases of the individual.
In conclusion, a thorough functional and phenotypic charac-
terization of human NK-like CD8+ T-cells will be fundamental in 
order to provide mechanistic insight into the functional adapta-
tion of these cells to aging, autoimmunity, inflammation, viral, 
and tumor antigens and toward their exploitation in potential 
therapeutic applications.
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